Archive for July, 2016

RECALL of Diocto Liquid Docusate

PharmaTech LLC, the manufacturer of the branded product Diocto Liquid (docusate sodium solution), is recalling all lots of Diocto due to a risk of product contamination with Burkholderia cepacia.  Contract Pharmacy Services purchased limited supplies of this product in the past.  Those facilities that may have received this product will be contacted directly by CPS so that the product can be removed from active stock. If there is a chance that you have purchased this product from a source other than[...]
Continue Reading

Quarterly Report – Biologics for Rheumatoid Arthritis & Psoriasis

Biologic response modifiers (biologics for short) are medications that are genetically engineered from a living organism, such as a virus, gene or protein, to stimulate the body’s natural response to infection and disease.  They target proteins, cells and pathways responsible for the symptoms and damage of rheumatoid arthritis and other types of inflammatory illnesses.  The proteins targeted include tumor necrosis factor (TNF), interleukin inhibitors (IL) and T-cell activation. Biologic medications are less toxic to the liver, kidneys and bone marrow compared[...]
Continue Reading

Quarterly Drug Information Corner

Vaccine Update Intra Nasal Influenza Vaccine – The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) voted to recommend that the live attenuated influenza vaccine (LAIV; FluMist quadrivalent) should not be used in the United States for the 2016 to 2017 influenza season.   This is an interim recommendation, as there may be additional data obtained prior to the start of this year’s flu season. Data has shown during the last three flu seasons (2013-2014 through[...]
Continue Reading

UPDATE – Liquid Docusate

The Centers for Disease Control (CDC) is continuing the investigation into a multistate outbreak of infections caused by Burkholderia cepacia that may be linked to contaminated liquid docusate (Colace).  At this time, the CDC recommends that clinicians should not recommend the use of any liquid docusate products.  This recommendation has been expanded to all patient populations.  If a stool softener is needed and the patient is unable to swallow pills, an alternative would be to use a docusate 100 mg gelcap. [...]
Continue Reading


Bicillin L-A Shortage Update CPS currently has a limited supply of Bicillin L-A (penicillin G Benzathine) injection in stock.  All products are currently on backorder due to manufacturing delays.   CPS is in close contact with wholesalers regarding this shortage and it is anticipated the manufacture will be shipping product soon. Bicillin L-A is penicillinase-sensitive penicillin indicated for mild to moderate upper respiratory Streptococcus infections and syphilis.  Bicillin L-A is the recommended treatment for syphilis and is the only option for pregnant women[...]
Continue Reading
Footer Logo